Observational studyMedicina (Kaunas, Lithuania)2025

The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival.

Inés Noval-Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.